{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:00:58Z","timestamp":1785564058368,"version":"3.56.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00216-014-7772-1","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T08:21:51Z","timestamp":1397118111000},"page":"3459-3476","source":"Crossref","is-referenced-by-count":62,"title":["Multi-analytical platform metabolomic approach to study miltefosine mechanism of action and resistance in Leishmania"],"prefix":"10.1007","volume":"406","author":[{"given":"Gisele A. B.","family":"Canuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson A.","family":"Castilho-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina F. M.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Barbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"L\u00f3pez-Gonz\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"7772_CR1","unstructured":"Organization WH Technical report series no. 949. In: Control of the leishmaniasis: report of a meeting of the World Health Organization Expert Committee on the Control of Leishmaniases, Geneva, 2010. pp 22\u201326"},{"issue":"5","key":"7772_CR2","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, Team WLC (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7(5):e35671","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"7772_CR3","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","volume":"31","author":"J Alvar","year":"2013","unstructured":"Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG (2013) Case study for a vaccine against leishmaniasis. Vaccine 31(Suppl 2):B244\u2013B249","journal-title":"Vaccine"},{"issue":"10","key":"7772_CR4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.intimp.2011.05.008","volume":"11","author":"R Nagill","year":"2011","unstructured":"Nagill R, Kaur S (2011) Vaccine candidates for leishmaniasis: a review. Int Immunopharmacol 11(10):1464\u20131488","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"7772_CR5","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","volume":"17","author":"SL Croft","year":"2011","unstructured":"Croft SL, Olliaro P (2011) Leishmaniasis chemotherapy\u2013challenges and opportunities. Clin Microbiol Infect 17(10):1478\u20131483","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"7772_CR6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","volume":"10","author":"J Griensven van","year":"2010","unstructured":"van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M (2010) Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10(3):184\u2013194","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"7772_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","volume":"14","author":"S Sundar","year":"2013","unstructured":"Sundar S, Chakravarty J (2013) Leishmaniasis: an update of current pharmacotherapy. Expert Opin Pharmacother 14(1):53\u201363","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"7772_CR8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","volume":"22","author":"J Alvar","year":"2006","unstructured":"Alvar J, Yactayo S, Bern C (2006) Leishmaniasis and poverty. Trends Parasitol 22(12):552\u2013557","journal-title":"Trends Parasitol"},{"issue":"22","key":"7772_CR9","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","volume":"347","author":"S Sundar","year":"2002","unstructured":"Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J (2002) Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347(22):1739\u20131746","journal-title":"N Engl J Med"},{"issue":"11","key":"7772_CR10","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ (2012) Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 67(11):2576\u20132597","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"7772_CR11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","volume":"53","author":"D Kumar","year":"2009","unstructured":"Kumar D, Kulshrestha A, Singh R, Salotra P (2009) In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Antimicrob Agents Chemother 53(2):835\u2013838","journal-title":"Antimicrob Agents Chemother"},{"key":"7772_CR12","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/cddis.2011.83","volume":"2","author":"W Moreira","year":"2011","unstructured":"Moreira W, Leprohon P, Ouellette M (2011) Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell Death Dis 2:e201","journal-title":"Cell Death Dis"},{"issue":"11","key":"7772_CR13","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","volume":"56","author":"S Rijal","year":"2013","unstructured":"Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC (2013) Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 56(11):1530\u20131538","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7772_CR14","first-page":"85","volume":"25","author":"S Sundar","year":"2012","unstructured":"Sundar S, Chakravarty J (2012) Recent advances in the diagnosis and treatment of kala-azar. Natl Med J India 25(2):85\u201389","journal-title":"Natl Med J India"},{"issue":"3","key":"7772_CR15","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.48.3.852-859.2004","volume":"48","author":"C Paris","year":"2004","unstructured":"Paris C, Loiseau PM, Bories C, Br\u00e9ard J (2004) Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 48(3):852\u2013859","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"7772_CR16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrmicro2929","volume":"11","author":"WR Proto","year":"2013","unstructured":"Proto WR, Coombs GH, Mottram JC (2013) Cell death in parasitic protozoa: regulated or incidental? Nat Rev Microbiol 11(1):58\u201366","journal-title":"Nat Rev Microbiol"},{"issue":"24","key":"7772_CR17","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1021\/jm070595+","volume":"50","author":"JM Saugar","year":"2007","unstructured":"Saugar JM, Delgado J, Hornillos V, Luque-Ortega JR, Amat-Guerri F, Acu\u00f1a AU, Rivas L (2007) Synthesis and biological evaluation of fluorescent leishmanicidal analogues of hexadecylphosphocholine (miltefosine) as probes of antiparasite mechanisms. J Med Chem 50(24):5994\u20136003","journal-title":"J Med Chem"},{"issue":"1\u20132","key":"7772_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-6851(02)00220-7","volume":"125","author":"R Zufferey","year":"2002","unstructured":"Zufferey R, Mamoun CB (2002) Choline transport in Leishmania major promastigotes and its inhibition by choline and phosphocholine analogs. Mol Biochem Parasitol 125(1\u20132):127\u2013134","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"7772_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00278-4","volume":"111","author":"H Lux","year":"2000","unstructured":"Lux H, Heise N, Klenner T, Hart D, Opperdoes FR (2000) Ether\u2013lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether\u2013lipid analogues in Leishmania. Mol Biochem Parasitol 111(1):1\u201314","journal-title":"Mol Biochem Parasitol"},{"issue":"3","key":"7772_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/138920009787846332","volume":"10","author":"G Barratt","year":"2009","unstructured":"Barratt G, Saint-Pierre-Chazalet M, Loiseau PM (2009) Cellular transport and lipid interactions of miltefosine. Curr Drug Metab 10(3):247\u2013255","journal-title":"Curr Drug Metab"},{"issue":"3","key":"7772_CR21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00216-011-5520-3","volume":"402","author":"L Imbert","year":"2012","unstructured":"Imbert L, Ramos RG, Libong D, Abreu S, Loiseau PM, Chaminade P (2012) Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI\/MS, and multivariate data analysis. Anal Bioanal Chem 402(3):1169\u20131182","journal-title":"Anal Bioanal Chem"},{"key":"7772_CR22","doi-asserted-by":"crossref","unstructured":"Rakotomanga M, Saint-Pierre-Chazalet M, Loiseau PM (2005) Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions. Antimicrob Agents Chemother 49(7):2677\u20132686","DOI":"10.1128\/AAC.49.7.2677-2686.2005"},{"issue":"1","key":"7772_CR23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.molbiopara.2012.01.005","volume":"183","author":"F Getachew","year":"2012","unstructured":"Getachew F, Gedamu L (2012) Leishmania donovani mitochondrial iron superoxide dismutase A is released into the cytosol during miltefosine induced programmed cell death. Mol Biochem Parasitol 183(1):42\u201351","journal-title":"Mol Biochem Parasitol"},{"issue":"4","key":"7772_CR24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","volume":"51","author":"JR Luque-Ortega","year":"2007","unstructured":"Luque-Ortega JR, Rivas L (2007) Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes. Antimicrob Agents Chemother 51(4):1327\u20131332","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"7772_CR25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/mol.111.072322","volume":"80","author":"X Zuo","year":"2011","unstructured":"Zuo X, Djordjevic JT, Bijosono Oei J, Desmarini D, Schibeci SD, Jolliffe KA, Sorrell TC (2011) Miltefosine induces apoptosis-like cell death in yeast via Cox9p in cytochrome c oxidase. Mol Pharmacol 80(3):476\u2013485","journal-title":"Mol Pharmacol"},{"issue":"19","key":"7772_CR26","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1111\/febs.12449","volume":"280","author":"M Das","year":"2013","unstructured":"Das M, Saudagar P, Sundar S, Dubey VK (2013) Miltefosine\u2013unresponsive Leishmania donovani has a greater ability than miltefosine\u2013responsive L. donovani to resist reactive oxygen species. FEBS J 280(19):4807\u20134815","journal-title":"FEBS J"},{"issue":"2","key":"7772_CR27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2013.08.004","volume":"135","author":"J Mishra","year":"2013","unstructured":"Mishra J, Singh S (2013) Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death. Exp Parasitol 135(2):397\u2013406","journal-title":"Exp Parasitol"},{"issue":"50","key":"7772_CR28","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","volume":"278","author":"FJ P\u00e9rez-Victoria","year":"2003","unstructured":"P\u00e9rez-Victoria FJ, Gamarro F, Ouellette M, Castanys S (2003) Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance. J Biol Chem 278(50):49965\u201349971","journal-title":"J Biol Chem"},{"issue":"8","key":"7772_CR29","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","volume":"47","author":"FJ P\u00e9rez-Victoria","year":"2003","unstructured":"P\u00e9rez-Victoria FJ, Castanys S, Gamarro F (2003) Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrob Agents Chemother 47(8):2397\u20132403","journal-title":"Antimicrob Agents Chemother"},{"issue":"33","key":"7772_CR30","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","volume":"281","author":"FJ P\u00e9rez-Victoria","year":"2006","unstructured":"P\u00e9rez-Victoria FJ, S\u00e1nchez-Ca\u00f1ete MP, Castanys S, Gamarro F (2006) Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites. J Biol Chem 281(33):23766\u201323775","journal-title":"J Biol Chem"},{"issue":"4","key":"7772_CR31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/AAC.01694-08","volume":"53","author":"MP S\u00e1nchez-Ca\u00f1ete","year":"2009","unstructured":"S\u00e1nchez-Ca\u00f1ete MP, Carvalho L, P\u00e9rez-Victoria FJ, Gamarro F, Castanys S (2009) Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug. Antimicrob Agents Chemother 53(4):1305\u20131313","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"7772_CR32","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.00587-08","volume":"52","author":"E Castanys-Mu\u00f1oz","year":"2008","unstructured":"Castanys-Mu\u00f1oz E, P\u00e9rez-Victoria JM, Gamarro F, Castanys S (2008) Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement. Antimicrob Agents Chemother 52(10):3573\u20133579","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"7772_CR33","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","volume":"45","author":"JM P\u00e9rez-Victoria","year":"2001","unstructured":"P\u00e9rez-Victoria JM, P\u00e9rez-Victoria FJ, Parodi-Talice A, Jim\u00e9nez IA, Ravelo AG, Castanys S, Gamarro F (2001) Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator. Antimicrob Agents Chemother 45(9):2468\u20132474","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"7772_CR34","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","volume":"6","author":"AC Coelho","year":"2012","unstructured":"Coelho AC, Boisvert S, Mukherjee A, Leprohon P, Corbeil J, Ouellette M (2012) Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing. PLoS Negl Trop Dis 6(2):e1512","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"7772_CR35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","volume":"18","author":"S Cojean","year":"2012","unstructured":"Cojean S, Houz\u00e9 S, Haouchine D, Huteau F, Lariven S, Hubert V, Michard F, Bories C, Pratlong F, Le Bras J, Loiseau PM, Matheron S (2012) Leishmania resistance to miltefosine associated with genetic marker. Emerg Infect Dis 18(4):704\u2013706","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"7772_CR36","doi-asserted-by":"crossref","first-page":"e1657","DOI":"10.1371\/journal.pntd.0001657","volume":"6","author":"V Bhandari","year":"2012","unstructured":"Bhandari V, Kulshrestha A, Deep DK, Stark O, Prajapati VK, Ramesh V, Sundar S, Schonian G, Dujardin JC, Salotra P (2012) Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. PLoS Negl Trop Dis 6(5):e1657","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"7772_CR37","doi-asserted-by":"crossref","first-page":"e1974","DOI":"10.1371\/journal.pntd.0001974","volume":"6","author":"R Garc\u00eda-Hern\u00e1ndez","year":"2012","unstructured":"Garc\u00eda-Hern\u00e1ndez R, Manzano JI, Castanys S, Gamarro F (2012) Leishmania donovani develops resistance to drug combinations. PLoS Negl Trop Dis 6(12):e1974","journal-title":"PLoS Negl Trop Dis"},{"issue":"18","key":"7772_CR38","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/elps.200700851","volume":"29","author":"L Xiayan","year":"2008","unstructured":"Xiayan L, Legido-Quigley C (2008) Advances in separation science applied to metabonomics. Electrophoresis 29(18):3724\u20133736","journal-title":"Electrophoresis"},{"key":"7772_CR39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.aca.2012.05.049","volume":"750","author":"A Smolinska","year":"2012","unstructured":"Smolinska A, Blanchet L, Buydens LM, Wijmenga SS (2012) NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 750:82\u201397","journal-title":"Anal Chim Acta"},{"issue":"4","key":"7772_CR40","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00216-012-6188-z","volume":"404","author":"GA Barding","year":"2012","unstructured":"Barding GA, Salditos R, Larive CK (2012) Quantitative NMR for bioanalysis and metabolomics. Anal Bioanal Chem 404(4):1165\u20131179","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"7772_CR41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jbiosc.2013.01.004","volume":"116","author":"SP Putri","year":"2013","unstructured":"Putri SP, Yamamoto S, Tsugawa H, Fukusaki E (2013) Current metabolomics: technological advances. J Biosci Bioeng 116(1):9\u201316","journal-title":"J Biosci Bioeng"},{"issue":"4","key":"7772_CR42","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jpba.2011.02.001","volume":"55","author":"C Barbas","year":"2011","unstructured":"Barbas C, Moraes EP, Villase\u00f1or A (2011) Capillary electrophoresis as a metabolomics tool for non-targeted fingerprinting of biological samples. J Pharm Biomed Anal 55(4):823\u2013831","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"7772_CR43","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.4155\/bio.12.100","volume":"4","author":"D Rojo","year":"2012","unstructured":"Rojo D, Barbas C, Rup\u00e9rez FJ (2012) LC-MS metabolomics of polar compounds. Bioanalysis 4(10):1235\u20131243","journal-title":"Bioanalysis"},{"issue":"3","key":"7772_CR44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11306-010-0254-3","volume":"7","author":"MM Koek","year":"2011","unstructured":"Koek MM, Jellema RH, van der Greef J, Tas AC, Hankemeier T (2011) Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives. Metabolomics 7(3):307\u2013328","journal-title":"Metabolomics"},{"issue":"22","key":"7772_CR45","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1021\/ac2021823","volume":"83","author":"DJ Creek","year":"2011","unstructured":"Creek DJ, Jankevics A, Breitling R, Watson DG, Barrett MP, Burgess KE (2011) Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. Anal Chem 83(22):8703\u20138710","journal-title":"Anal Chem"},{"key":"7772_CR46","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2741\/3840","volume":"16","author":"JM Requena","year":"2011","unstructured":"Requena JM (2011) Lights and shadows on gene organization and regulation of gene expression in Leishmania. Front Biosci (Landmark Ed) 16:2069\u20132085","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"10","key":"7772_CR47","doi-asserted-by":"crossref","first-page":"e26660","DOI":"10.1371\/journal.pone.0026660","volume":"6","author":"B Chawla","year":"2011","unstructured":"Chawla B, Jhingran A, Panigrahi A, Stuart KD, Madhubala R (2011) Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin -susceptible -resistant Leishmania donovani. PLoS One 6(10):e26660","journal-title":"PLoS One"},{"issue":"9","key":"7772_CR48","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jprot.2011.05.005","volume":"74","author":"D Paape","year":"2011","unstructured":"Paape D, Aebischer T (2011) Contribution of proteomics of Leishmania spp. to the understanding of differentiation, drug resistance mechanisms, vaccine and drug development. J Proteomics 74(9):1614\u20131624","journal-title":"J Proteomics"},{"issue":"1","key":"7772_CR49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1074\/mcp.M600319-MCP200","volume":"6","author":"B Vergnes","year":"2007","unstructured":"Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, Ouellette M (2007) A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6(1):88\u2013101","journal-title":"Mol Cell Proteomics"},{"key":"7772_CR50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1752-0509-3-57","volume":"3","author":"MA Doyle","year":"2009","unstructured":"Doyle MA, MacRae JI, De Souza DP, Saunders EC, McConville MJ, Liki\u0107 VA (2009) LeishCyc: a biochemical pathways database for Leishmania major. BMC Syst Biol 3:57","journal-title":"BMC Syst Biol"},{"issue":"2","key":"7772_CR51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molbiopara.2011.10.003","volume":"181","author":"DJ Creek","year":"2012","unstructured":"Creek DJ, Anderson J, McConville MJ, Barrett MP (2012) Metabolomic analysis of trypanosomatid protozoa. Mol Biochem Parasitol 181(2):73\u201384","journal-title":"Mol Biochem Parasitol"},{"key":"7772_CR52","doi-asserted-by":"crossref","unstructured":"McConville MJ, Naderer T (2011) Metabolic pathways required for the intracellular survival of Leishmania. Annu Rev Microbiol 65:543\u2013561","DOI":"10.1146\/annurev-micro-090110-102913"},{"issue":"4","key":"7772_CR53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pt.2007.02.004","volume":"23","author":"FR Opperdoes","year":"2007","unstructured":"Opperdoes FR, Coombs GH (2007) Metabolism of Leishmania: proven and predicted. Trends Parasitol 23(4):149\u2013158","journal-title":"Trends Parasitol"},{"issue":"9","key":"7772_CR54","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1017\/S0031182009992022","volume":"137","author":"RA Scheltema","year":"2010","unstructured":"Scheltema RA, Decuypere S, T'kindt R, Dujardin JC, Coombs GH, Breitling R (2010) The potential of metabolomics for Leishmania research in the post-genomics era. Parasitology 137(9):1291\u20131302","journal-title":"Parasitology"},{"issue":"8","key":"7772_CR55","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1021\/pr3003358","volume":"11","author":"SD Lamour","year":"2012","unstructured":"Lamour SD, Choi BS, Keun HC, M\u00fcller I, Saric J (2012) Metabolic characterization of Leishmania major infection in activated and nonactivated macrophages. J Proteome Res 11(8):4211\u20134222","journal-title":"J Proteome Res"},{"issue":"12","key":"7772_CR56","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/elps.201200007","volume":"33","author":"GA Canuto","year":"2012","unstructured":"Canuto GA, Castilho-Martins EA, Tavares M, L\u00f3pez-Gonz\u00e1lvez A, Rivas L, Barbas C (2012) CE-ESI-MS metabolic fingerprinting of Leishmania resistance to antimony treatment. Electrophoresis 33(12):1901\u20131910","journal-title":"Electrophoresis"},{"issue":"11","key":"7772_CR57","doi-asserted-by":"crossref","first-page":"e904","DOI":"10.1371\/journal.pntd.0000904","volume":"4","author":"R T'Kindt","year":"2010","unstructured":"T'Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, Breitling R, Watson DG, Coombs GH, Decuypere S (2010) Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis 4(11):e904","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"7772_CR58","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","volume":"22","author":"K Seifert","year":"2003","unstructured":"Seifert K, Matu S, Javier P\u00e9rez-Victoria F, Castanys S, Gamarro F, Croft SL (2003) Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents 22(4):380\u2013387","journal-title":"Int J Antimicrob Agents"},{"key":"7772_CR59","doi-asserted-by":"crossref","unstructured":"Suhre K, Schmitt-Kopplin P (2008) MassTRIX: mass translator into pathways. Nucleic Acids Res 36 (Web Server issue):W481-484.","DOI":"10.1093\/nar\/gkn194"},{"key":"7772_CR60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-511X-9-33","volume":"9","author":"JM Jim\u00e9nez-L\u00f3pez","year":"2010","unstructured":"Jim\u00e9nez-L\u00f3pez JM, R\u00edos-Marco P, Marco C, Segovia JL, Carrasco MP (2010) Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids. Lipids Health Dis 9:33","journal-title":"Lipids Health Dis"},{"issue":"8","key":"7772_CR61","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/AAC.48.8.3010-3015.2004","volume":"48","author":"NK Verma","year":"2004","unstructured":"Verma NK, Dey CS (2004) Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother 48(8):3010\u20133015","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"7772_CR62","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/AAC.01123-06","volume":"51","author":"M Rakotomanga","year":"2007","unstructured":"Rakotomanga M, Blanc S, Gaudin K, Chaminade P, Loiseau PM (2007) Miltefosine affects lipid metabolism in Leishmania donovani promastigotes. Antimicrob Agents Chemother 51(4):1425\u20131430","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"7772_CR63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.chroma.2008.07.080","volume":"1209","author":"RG Ramos","year":"2008","unstructured":"Ramos RG, Libong D, Rakotomanga M, Gaudin K, Loiseau PM, Chaminade P (2008) Comparison between charged aerosol detection and light scattering detection for the analysis of Leishmania membrane phospholipids. J Chromatogr A 1209(1\u20132):88\u201394","journal-title":"J Chromatogr A"},{"key":"7772_CR64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-4899-0179-8_53","volume":"416","author":"CC Geilen","year":"1996","unstructured":"Geilen CC, Wieder T, Orfanos CE (1996) Phosphatidylcholine biosynthesis as a target for phospholipid analogues. Adv Exp Med Biol 416:333\u2013336","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"7772_CR65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","volume":"30","author":"K Seifert","year":"2007","unstructured":"Seifert K, P\u00e9rez-Victoria FJ, Stettler M, S\u00e1nchez-Ca\u00f1ete MP, Castanys S, Gamarro F, Croft SL (2007) Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Int J Antimicrob Agents 30(3):229\u2013235","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"7772_CR66","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00216-010-4139-0","volume":"398","author":"R T'Kindt","year":"2010","unstructured":"T'Kindt R, Jankevics A, Scheltema RA, Zheng L, Watson DG, Dujardin JC, Breitling R, Coombs GH, Decuypere S (2010) Towards an unbiased metabolic profiling of protozoan parasites: optimisation of a Leishmania sampling protocol for HILIC-orbitrap analysis. Anal Bioanal Chem 398(5):2059\u20132069","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"7772_CR67","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/anie.200300639","volume":"44","author":"RL Krauth-Siegel","year":"2005","unstructured":"Krauth-Siegel RL, Bauer H, Schirmer RH (2005) Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. Angew Chem Int Ed Engl 44(5):690\u2013715","journal-title":"Angew Chem Int Ed Engl"},{"issue":"29","key":"7772_CR68","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.1202593109","volume":"109","author":"PK Fyfe","year":"2012","unstructured":"Fyfe PK, Westrop GD, Silva AM, Coombs GH, Hunter WN (2012) Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation. Proc Natl Acad Sci U S A 109(29):11693\u201311698","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"38","key":"7772_CR69","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","volume":"279","author":"S Wyllie","year":"2004","unstructured":"Wyllie S, Cunningham ML, Fairlamb AH (2004) Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J Biol Chem 279(38):39925\u201339932","journal-title":"J Biol Chem"},{"issue":"30","key":"7772_CR70","doi-asserted-by":"crossref","first-page":"19800","DOI":"10.1074\/jbc.M901066200","volume":"284","author":"I Darlyuk","year":"2009","unstructured":"Darlyuk I, Goldman A, Roberts SC, Ullman B, Rentsch D, Zilberstein D (2009) Arginine homeostasis and transport in the human pathogen Leishmania donovani. J Biol Chem 284(30):19800\u201319807","journal-title":"J Biol Chem"},{"issue":"11","key":"7772_CR71","doi-asserted-by":"crossref","first-page":"e27818","DOI":"10.1371\/journal.pone.0027818","volume":"6","author":"EA Castilho-Martins","year":"2011","unstructured":"Castilho-Martins EA, Laranjeira da Silva MF, dos Santos MG, Muxel SM, Floeter-Winter LM (2011) Axenic Leishmania amazonensis promastigotes sense both the external and internal arginine pool distinctly regulating the two transporter-coding genes. PLoS One 6(11):e27818","journal-title":"PLoS One"},{"issue":"1","key":"7772_CR72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-1097(97)00401-1","volume":"156","author":"NK Basu","year":"1997","unstructured":"Basu NK, Kole L, Ghosh A, Das PK (1997) Isolation of a nitric oxide synthase from the protozoan parasite, Leishmania donovani. FEMS Microbiol Lett 156(1):43\u201347","journal-title":"FEMS Microbiol Lett"},{"issue":"4","key":"7772_CR73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00430-003-0176-z","volume":"192","author":"M Genestra","year":"2003","unstructured":"Genestra M, de Souza WJ, Cysne-Finkelstein L, Leon LL (2003) Comparative analysis of the nitric oxide production by Leishmania sp. Med Microbiol Immunol 192(4):217\u2013223","journal-title":"Med Microbiol Immunol"},{"issue":"31","key":"7772_CR74","doi-asserted-by":"crossref","first-page":"27706","DOI":"10.1074\/jbc.M110.213553","volume":"286","author":"EC Saunders","year":"2011","unstructured":"Saunders EC, Ng WW, Chambers JM, Ng M, Naderer T, Kr\u00f6mer JO, Likic VA, McConville MJ (2011) Isotopomer profiling of Leishmania mexicana promastigotes reveals important roles for succinate fermentation and aspartate uptake in tricarboxylic acid cycle (TCA) anaplerosis, glutamate synthesis, and growth. J Biol Chem 286(31):27706\u201327717","journal-title":"J Biol Chem"},{"issue":"1","key":"7772_CR75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00726-010-0812-z","volume":"42","author":"E Inbar","year":"2012","unstructured":"Inbar E, Canepa GE, Carrillo C, Glaser F, Suter Grotemeyer M, Rentsch D, Zilberstein D, Pereira CA (2012) Lysine transporters in human trypanosomatid pathogens. Amino Acids 42(1):347\u2013360","journal-title":"Amino Acids"},{"issue":"1","key":"7772_CR76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-4894(77)90066-2","volume":"42","author":"MW Simon","year":"1977","unstructured":"Simon MW, Mukkada AJ (1977) Leishmania tropica: regulation and specificity of the methionine transport system in promastigotes. Exp Parasitol 42(1):97\u2013105","journal-title":"Exp Parasitol"},{"issue":"5","key":"7772_CR77","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1550-7408.2008.00346.x","volume":"55","author":"LS Paes","year":"2008","unstructured":"Paes LS, Galvez Rojas RL, Daliry A, Floeter-Winter LM, Ramirez MI, Silber AM (2008) Active transport of glutamate in Leishmania (Leishmania) amazonensis. J Eukaryot Microbiol 55(5):382\u2013387","journal-title":"J Eukaryot Microbiol"},{"issue":"12","key":"7772_CR78","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.bbamcr.2006.08.019","volume":"1763","author":"PA Michels","year":"2006","unstructured":"Michels PA, Bringaud F, Herman M, Hannaert V (2006) Metabolic functions of glycosomes in trypanosomatids. Biochim Biophys Acta 1763(12):1463\u20131477","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"7772_CR79","doi-asserted-by":"crossref","first-page":"11674","DOI":"10.1074\/jbc.M006850200","volume":"276","author":"ML Ginger","year":"2001","unstructured":"Ginger ML, Chance ML, Sadler IH, Goad LJ (2001) The biosynthetic incorporation of the intact leucine skeleton into sterol by the trypanosomatid Leishmania mexicana. J Biol Chem 276(15):11674\u201311682","journal-title":"J Biol Chem"},{"issue":"2","key":"7772_CR80","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molbiopara.2010.10.006","volume":"175","author":"A Alloatti","year":"2011","unstructured":"Alloatti A, Uttaro AD (2011) Highly specific methyl-end fatty-acid desaturases of trypanosomatids. Mol Biochem Parasitol 175(2):126\u2013132","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"7772_CR81","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/BJ20121262","volume":"449","author":"E Inbar","year":"2013","unstructured":"Inbar E, Schlisselberg D, Suter Grotemeyer M, Rentsch D, Zilberstein D (2013) A versatile proline\/alanine transporter in the unicellular pathogen Leishmania donovani regulates amino acid homoeostasis and osmotic stress responses. Biochem J 449(2):555\u2013566","journal-title":"Biochem J"},{"issue":"8","key":"7772_CR82","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1371\/journal.pone.0012443","volume":"5","author":"A Weing\u00e4rtner","year":"2010","unstructured":"Weing\u00e4rtner A, Drobot B, Herrmann A, S\u00e1nchez-Ca\u00f1ete MP, Gamarro F, Castanys S, G\u00fcnther Pomorski T (2010) Disruption of the lipid-transporting LdMT-LdRos3 complex in Leishmania donovani affects membrane lipid asymmetry but not host cell invasion. PLoS One 5(8):e12443","journal-title":"PLoS One"},{"key":"7772_CR83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/bse0510081","volume":"51","author":"T Naderer","year":"2011","unstructured":"Naderer T, McConville MJ (2011) Intracellular growth and pathogenesis of Leishmania parasites. Essays Biochem 51:81\u201395","journal-title":"Essays Biochem"},{"issue":"4","key":"7772_CR84","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0854.2006.00531.x","volume":"8","author":"A Haas","year":"2007","unstructured":"Haas A (2007) The phagosome: compartment with a license to kill. Traffic 8(4):311\u2013330","journal-title":"Traffic"},{"issue":"9","key":"7772_CR85","doi-asserted-by":"crossref","first-page":"e25273","DOI":"10.1371\/journal.pone.0025273","volume":"6","author":"S Verma","year":"2011","unstructured":"Verma S, Mehta A, Shaha C (2011) CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani. PLoS One 6(9):e25273","journal-title":"PLoS One"},{"issue":"1","key":"7772_CR86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molbiopara.2009.01.001","volume":"165","author":"RM Reguera","year":"2009","unstructured":"Reguera RM, Bala\u00f1a-Fouce R, Showalter M, Hickerson S, Beverley SM (2009) Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB\/c mice. Mol Biochem Parasitol 165(1):48\u201356","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"7772_CR87","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1096\/fj.07-9254com","volume":"22","author":"D Rosenzweig","year":"2008","unstructured":"Rosenzweig D, Smith D, Opperdoes F, Stern S, Olafson RW, Zilberstein D (2008) Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J 22(2):590\u2013602","journal-title":"FASEB J"},{"issue":"9","key":"7772_CR88","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1017\/S0031182010000077","volume":"137","author":"EC Saunders","year":"2010","unstructured":"Saunders EC, DE Souza DP, Naderer T, Sernee MF, Ralton JE, Doyle MA, Macrae JI, Chambers JL, Heng J, Nahid A, Likic VA, McConville MJ (2010) Central carbon metabolism of Leishmania parasites. Parasitology 137(9):1303\u20131313","journal-title":"Parasitology"},{"issue":"7","key":"7772_CR89","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/AAC.45.7.2023-2029.2001","volume":"45","author":"M Chen","year":"2001","unstructured":"Chen M, Zhai L, Christensen SB, Theander TG, Kharazmi A (2001) Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob Agents Chemother 45(7):2023\u20132029","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"7772_CR90","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/AAC.00520-11","volume":"55","author":"L Carvalho","year":"2011","unstructured":"Carvalho L, Luque-Ortega JR, L\u00f3pez-Mart\u00edn C, Castanys S, Rivas L, Gamarro F (2011) The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase. Antimicrob Agents Chemother 55(9):4204\u20134421","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-014-7772-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-014-7772-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-014-7772-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:15:08Z","timestamp":1565349308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-014-7772-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":90,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["7772"],"URL":"https:\/\/doi.org\/10.1007\/s00216-014-7772-1","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}